Search Results - "John, Christy S"
-
1
Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide
Published in Expert opinion on drug delivery (04-05-2017)“…Phase-0 studies, including microdosing, also called Exploratory Investigational New Drug (eIND) or exploratory clinical trials, are a regulatory framework for…”
Get more information
Journal Article -
2
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia
Published in The oncologist (Dayton, Ohio) (01-09-2018)“…On September 2, 2017, the U.S. Food and Drug Administration approved gemtuzumab ozogamicin (GO; Mylotarg; Pfizer, New York City, NY) for treatment of relapsed…”
Get full text
Journal Article -
3
Myasthenia Gravis
Published in The New England journal of medicine (30-03-2017)“…To the Editor: In his review on myasthenia gravis, Gilhus (Dec. 29 issue) 1 recommends against prescribing muscle relaxants, penicillamine, and certain…”
Get full text
Journal Article -
4
-
5
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines
Published in Cancer research (Chicago, Ill.) (15-01-1995)“…Thirteen tumor-derived cell lines of human and nonhuman origin and from various tissues were examined for the presence and density of sigma-1 and sigma-2…”
Get full text
Journal Article -
6
Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results
Published in The Journal of nuclear medicine (1978) (01-12-2002)“…The aim of this study was to investigate the potential of a new iodobenzamide, N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide (P-(123)I-MBA), to…”
Get full text
Journal Article -
7
Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors
Published in Cancer research (Chicago, Ill.) (15-09-1999)“…Sigma receptors are known to be expressed in a variety of human tumor cells, including breast, neural, and melanoma tumors. A very high density (1.0-1.5…”
Get full text
Journal Article -
8
Substituted Halogenated Arylsulfonamides: A New Class of σ Receptor Binding Tumor Imaging Agents
Published in Journal of medicinal chemistry (02-07-1998)“…The discovery of a series of novel halogenated arylsulfonamides (HAS) as new σ receptor binding tumor imaging agents is described. Several substituted…”
Get full text
Journal Article -
9
Myasthenia Gravis
Published in The New England journal of medicine (30-03-2017)Get full text
Journal Article -
10
Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1′-piperidinyl)ethyl]-3-[ 125I]iodo-4-methoxybenzamide (P[ 125I]MBA) for imaging breast cancer
Published in Nuclear medicine and biology (01-05-1999)“…The goal of this study was to investigate the potential use of a radioiodinated benzamide, N-[2-(1′-piperidinyl)ethyl]-3-iodo[ 125I]-4-methoxybenzamide (P[…”
Get full text
Journal Article -
11
Synthesis, In Vitro Binding, and Tissue Distribution of Radioiodinated 2-[ 125I] N-( N-Benzylpiperidin-4-yl)-2-Iodo Benzamide, 2-[ 125I]BP: A Potential σ Receptor Marker for Human Prostate Tumors
Published in Nuclear medicine and biology (01-04-1998)“…The preclinical evaluation of a σ receptor–specific radiopharmaceutical that binds to human prostate tumor cells with a high affinity is described. We have…”
Get full text
Journal Article -
12
Synthesis, in vitro validation and in vivo pharmacokinetics of [ 125I]N-[2-(4-Iodophenyl)Ethyl]- N-Methyl-2-(1-Piperidinyl) ethylamine: A high-affinity ligand for imaging sigma receptor positive tumors
Published in Nuclear medicine and biology (01-08-1996)“…N-[2-(4-iodophenyl)ethyl]- N-methyl-2-(1-piperidinyl)ethylamine, IPEMP, and the corresponding bromo derivative, BrPEMP, have been synthesized and…”
Get full text
Journal Article Conference Proceeding -
13
Myasthenia Gravis
Published in The New England journal of medicine (30-03-2017)Get full text
Journal Article -
14
99mTc-Labeled σ-Receptor-Binding Complex: Synthesis, Characterization, and Specific Binding to Human Ductal Breast Carcinoma (T47D) Cells
Published in Bioconjugate chemistry (28-05-1997)“…σ-Receptors have recently been shown to be expressed in a variety of human tumor cells. In an attempt to prepare 99mTc chelates that would bind to σ-receptors…”
Get full text
Journal Article -
15
-
16
Labelled sigma receptor ligands: can their role in neurology and oncology be extended?
Published in European Journal of Nuclear Medicine (01-02-2001)Get full text
Journal Article -
17
Sigma receptors are expressed in human non-small cell lung carcinoma
Published in Life sciences (1973) (1995)“…N-(2-piperidinoethyl)4-iodobenzamide), IPAB, was used to characterize sigma receptors in non-small cell lung cancer (NSCLC) cell lines. 125IPAB bound with high…”
Get more information
Journal Article -
18
Synthesis and evaluation of [ 18F] labeled benzamides: High affinity sigma receptor ligands for PET imaging
Published in Nuclear medicine and biology (01-05-1997)“…We have synthesized and characterized four new fluorinated halobenzamides as sigma receptor ligands for use with positron emission tomography (PET). All the…”
Get full text
Journal Article -
19
99m Tc-Labeled σ-Receptor-Binding Complex: Synthesis, Characterization, and Specific Binding to Human Ductal Breast Carcinoma (T47D) Cells
Published in Bioconjugate chemistry (01-05-1997)Get full text
Journal Article -
20
N,N′-Ethylene-di- l-Cysteine (EC) complexes of Ga(III) and In(III): Molecular modeling, thermodynamic stability and in vivo studies
Published in Nuclear medicine and biology (01-02-1995)“…There are several reports in the literature on the evaluation of chelates containing two nitrogens and two sulfurs (N 2S 2) as four coordinate ligands (in…”
Get full text
Journal Article